BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32984001)

  • 1. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway.
    Liu Y; Chang Y; He X; Cai Y; Jiang H; Jia R; Leng J
    Front Oncol; 2020; 10():1525. PubMed ID: 32984001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of mammalian target of rapamycin in Ishikawa and HEC-1A cells.
    Li X; Xiao L; Yang Y; Shen H; Zeng H; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):340-2. PubMed ID: 18563337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
    Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
    J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the ERK/MMP9 signaling pathway].
    Wu C; Cheng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
    Cao X; He GZ
    Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin inhibitor RAD001 sensitizes endometrial cancer cells to paclitaxel-induced apoptosis via the induction of autophagy.
    Wang H; Li D; Li X; Ou X; Liu S; Zhang Y; Ding J; Xie B
    Oncol Lett; 2016 Dec; 12(6):5029-5035. PubMed ID: 28105210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
    Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
    Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
    Du Y; Wang L; Chen S; Liu Y; Zhao Y
    Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z; Yu H
    Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway.
    Lin Q; Wang Y; Chen D; Sheng X; Liu J; Xiong H
    Oncol Lett; 2017 May; 13(5):3567-3571. PubMed ID: 28521459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].
    Guo RX; Lei J; Wang XY; Ge X; Hu DM; Ma XY; Li LX; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):129-33. PubMed ID: 23544495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
    Lei X; Guo J; Wang Y; Cui J; Feng B; Su Y; Zhao H; Yang W; Hu Y
    J BUON; 2019; 24(4):1555-1561. PubMed ID: 31646808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.
    Suh DS; Park SE; Jin H; Lee K; Bae J
    Oncogenesis; 2018 Jan; 7(1):3. PubMed ID: 29358688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
    Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
    Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway.
    Sun R; Sun X; Liu H; Li P
    Onco Targets Ther; 2019; 12():10863-10872. PubMed ID: 31849490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.